Smart thinking on cannabis Investor Presentation June 2020 THC - - PowerPoint PPT Presentation

1 THC GLOBAL GROUP LIMITED (ASX:THC)

Smart thinking on cannabis

THC Global Group Limited (ASX:THC)

Investor Presentation June 2020

2 THC GLOBAL GROUP LIMITED (ASX:THC)

Australia’s newest pharmaceutical company - delivered

Launched Affordable Medicines Range Acquired Clinics to Increase Accessibility Established Export Channels Achieved Dominant Market Position Positioned to Lead Pharma OTC Own Australian Bio-Pharma Factory Complete GMP Certification (EU and TGA) Launched Global Scale Medicines Supply Secured Upstream Cannabis Supply

3 THC GLOBAL GROUP LIMITED (ASX:THC)

Delivering in Four Core Areas

Global Supply of Medicines Direct Patient Healthcare Services World Class Pharma Production Four interconnected revenue centres addressing major global barriers to industry growth Turnkey Cultivation Solutions

4 THC GLOBAL GROUP LIMITED (ASX:THC)

Pharma Production Made World Class

Scalable Production

Production capacity scalable up to 1 million patients per annum with limited additional capex.

TGA & EU GMP Licenced

Pharma GMP cannabis medicines production with full EU compliance enabling export opportunities.

Reliable Supply Secured

Access to own cultivation facilities in addition to local Aust growers, and crude extract imports.

Onsite R&D Lab

Onsite labs enables product testing and validation in addition to production required for clinical trials.

Finished Goods Diversity

Developing capability for production of capsules, tablets, creams and other finished product forms.

White Label & Own Lines

Ability to service high volume bulk processing or white-labelled orders without limiting own production.

5 THC GLOBAL GROUP LIMITED (ASX:THC)

Pharma Production at Global Scale

Third Party Brands Canndeo Branded Medicines Pharmaceutical API Third Party Australian Growers THC Global Cultivation Sites International Raw Crude

6 THC GLOBAL GROUP LIMITED (ASX:THC)

Affordable and Accessible Medicines

Canndeo

7 THC GLOBAL GROUP LIMITED (ASX:THC)

Opening Australia’s Prescribing Market

Tetra Health CanndeoCare

1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 SAS-B Approvals

Solving the Affordability & Accessibility Gap

8 THC GLOBAL GROUP LIMITED (ASX:THC)

Capturing the New Pharma OTC Market

Unprecedented opportunity to dominate a new $200m+ market $200m+ Addressable Patient Market Order of Magnitude Volume Increase White Label Opportunity Canndeo Branded Medicines

9 THC GLOBAL GROUP LIMITED (ASX:THC)

Exporting to Global Markets

Delivering a global supply of affordable quality medicines 2020 2021+

10 THC GLOBAL GROUP LIMITED (ASX:THC)

Smart Businesses for the Canadian Market

Turnkey Cultivation Solutions Medicinal Cannabis

High growth businesses developed for the Canadian market with strong profitability potential

11 THC GLOBAL GROUP LIMITED (ASX:THC)

Laura Harvey Angela Macquire Diandra Phipps Sonny Didugu Steven Xu Ken Charteris Jarrod White Andrew Beehag

Global Management Team

12 THC GLOBAL GROUP LIMITED (ASX:THC)

Capital and Financial Overview

Key Information

ASX Code ASX:THC Listing Date May 2017 GICS Classification Pharmaceuticals, Biotechnology & Life Science Share Price

(3 June)

$0.44 Market Cap

(3 June)

$64.25 million Shares on Issue

(3 June)

146,028,486 Shareholders

(3 June)

8,888 Shareholders

Recent Financials

Cash

(31 March)

$2.26 million + $4m debt facility Property Plant and Equipment (2019) $18.4 million Existing Debt $4 million secured debt facility repayable 31 October 2021 2019 Group Revenue $4.79 million Revenue Growth 55% YoY (2018-19) 44% YoY on Q1 Cash Receipts

13 THC GLOBAL GROUP LIMITED (ASX:THC)

Disclaimer

14 THC GLOBAL GROUP LIMITED (ASX:THC)

CONTACT THC GLOBAL GROUP

ASX:THC

W E B

thc.global

C O R P O R A T E O F F I C E

Suite 4102 Level 41 Australia Square 264-278 George Street Sydney NSW 2000 Australia

E M A I L

corporate@thc.global